Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B.
Hee-Chul NamJi Won HanSoon Kyu LeeHyun YangHae Lim LeePil-Soo SungMyeong Jun SongJung Hyun KwonJeong Won JangU-Im ChangChang Wook KimSoon Woo NamSi Hyun BaeJong Young ChoiSeung Kew YoonJin Mo YangHee-Yeon KimPublished in: Journal of gastroenterology and hepatology (2024)
In this real-world study, switching to TAF was effective and safe in patients, with notable improvements in ALT levels, renal function, and BMD.